Search results
Earnings call: Investcorp Credit Management BDC reports growth in Q3 FY2024 By Investing.com
Investing.com· 8 hours agoInvestcorp Credit Management BDC (ICMB) announced an increase in net investment income for the third...
Zacks Research Comments on Eaton Co. plc’s Q2 2024 Earnings (NYSE:ETN)
ETF DAILY NEWS· 24 hours agoZacks Research analyst J. Saha now expects that the industrial products company will earn $2.58 per...
Fluent Inc (FLNT) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts Amid Revenue ...
GuruFocus.com via Yahoo Finance· 14 minutes agoThe focus is on return on ad spend (ROAS) rather than growth, with strong performance in subscriptions, health, and retail. Q: Can you describe the transition...seasonal and ...
Netflix ad-supported tier has 40 million monthly users, nearly double previous count
NBC Universal via AOL· 12 hours agoThe company said at the time that it was generating substantial...significance after it started to...
Earnings call: DHT Holdings announces robust Q1 2024 financials By Investing.com
Investing.com· 13 hours agoDHT Holdings, Inc. (NYSE:DHT) announced strong financial results in its first-quarter 2024 earnings...
Earnings call: Renalytix reports Q3 results, optimistic on KidneyIntelX By Investing.com
Investing.com· 8 hours agoRenalytix, a healthcare company specializing in kidney disease diagnostics, discussed its...
Earnings call: Gold Royalty reports robust Q1 growth and strategic partnerships By Investing.com
Investing.com· 1 day agoGold Royalty Corp. (NYSE American: GROY) has reported a strong start to the year, with a significant...
Earnings call: Capital Southwest reports robust fiscal year 2024 results By Investing.com
Investing.com· 10 hours agoCapital Southwest (NASDAQ:CSWC) has announced a strong financial performance for the fourth quarter...
Earnings call: Delcath Systems targets $10M quarterly revenue in 2024 By Investing.com
Investing.com· 1 day agoThe company has achieved revenue of $2 million from HEPZATO sales and $1.1 million from CHEMOSAT in...
Earnings call: Acumen Pharmaceuticals reports progress in ALTITUDE-AD study By Investing.com
Investing.com· 2 days agoAcumen Pharmaceuticals, in its Q1 2024 earnings call, detailed the initiation of the ALTITUDE-AD...